Vanda Pharmaceuticals announced it will participate in a fireside chat at the B. Riley Securities Mind, Muscle & Vision Summit in Boston on July 16, 2026. This event highlights Vanda's role as a leading biopharmaceutical company focused on innovative therapies for unmet medical needs. The participation offers investors insight into the company's strategies and future outlook. More information about Vanda can be found on their website and social media channels.
US-listed XRP ETFs attracted $28.14 million on August 26, marking the second-largest daily inflow in 2026, led by Bitwise with $13.12 million. Whale wallets accumulated about 460 million XRP tokens, the strongest since February, signaling strong inst...
At Bitcoin Asia 2026 in Hong Kong, former Binance CEO Changpeng Zhao predicted Bitcoin will overtake gold's significance during the next bull market cycle. While gold's market cap is about $32.4 trillion, Bitcoin currently holds $1.6 trillion, with Z...
In 2026, the United States saw its share of Bitcoin's total mining hashrate decline by about 0.823%, losing roughly 55 exahash per second (EH/s), though it remains the largest miner globally. Meanwhile, China and Russia increased their share of the g...
Meta has agreed to an $18 billion legal settlement, which translates to about $1 billion per year—an amount negligible compared to its substantial revenue and earnings. The settlement resolves regulatory uncertainties, allowing Meta to focus on its c...
Genius Group, after selling its entire Bitcoin reserve to repay $8.5 million in debt, plans to rebuild its Bitcoin and AI treasuries to a combined $1.6 billion by fiscal year 2031. The company aims to grow total assets to $2 billion and will fund tre...
